Akèy › Maladi Crohn › Texas
Etid klinik pou Maladi Crohn nan Texas
35 etid pou Maladi Crohn ap chèche patisipan nan sit nan Texas.
Vil nan Texas
- Houston17 etid
- Tyler16 etid
- San Antonio15 etid
- Dallas10 etid
- Lubbock10 etid
- Lewisville9 etid
- Round Rock7 etid
- Fort Worth6 etid
- The Woodlands6 etid
- Arlington5 etid
- Garland4 etid
- Austin3 etid
- League City3 etid
Tèks ofisyèl etid la (Anglè)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- ak 3 plis
Ap rekriteFaz 3
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Baylor University Medical Center ( Site 5031), Dallas
- Epic Medical Research - Mesquite ( Site 5153), Denton
- Baylor College of Medicine Medical Center ( Site 5020), Houston
- ak 6 plis
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- ak 9 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- ak 7 plis
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cook Childrens Medical Center, Fort Worth
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gi Alliance - Cedar Park /ID# 268153, Cedar Park
- Houston Methodist Hospital /ID# 265533, Houston
- Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
- ak 3 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- DFW Clinical Trials, Carrollton
- Lubbock Gastroenterology, Lubbock
- Gastroenterology Research of America, LLC, San Antonio
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- The University of Texas at Austin, Austin
- DFW Clinical Trials, Carrollton
- Baylor University Medical Center, Dallas
- ak 5 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
Ap rekriteFaz 3
Laj 3 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Novel Research, LLC, Bellaire
- One of a Kind Clinical research Center TX LLC, Kingwood
- Southern Star Research Institute, LLC, San Antonio
- ak 1 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- ak 2 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Inquest Clinical Research-Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center-Site Number: 8400098, Dallas
- Valley Institute of Research-Site Number: 8400004, Harlingen
- ak 8 plis
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
- SMS Clinical Research-Site Number: 8400035, Mesquite
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
- ak 2 plis
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184944A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- GI Alliance - Cedar Park, Cedar Park
- North Texas Gastroenterology, Denton
- The University of Texas Health Science Center at Houston, Houston
- ak 3 plis
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
Ap rekriteFaz 3
Laj 2 a 19 · Tout sèks · Mizajou Sep 22, 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Texas Digestive Disease Consultants Cedar Park, Cedar Park
- GI Alliance - Digestive Health Associates of Texas, Dallas
- The University of Texas Health Science Center at Houston, Houston
- ak 7 plis
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754Standardized Microbiota Transplant Therapy in Crohn's Disease
- UT Southwestern, Dallas
Ap rekriteFaz 2
Laj 18 a 89 · Tout sèks · Mizajou Sep 8, 2026 · NCT06631586A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT04372108A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Tyler Research Institute, LLC, Tyler
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cook Children's Medical Center, Fort Worth
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Aug 24, 2026 · NCT05509777Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173HB-adMSCs for the Treatment of Crohn's Disease
- Hope Biosciences Research Foundation, Sugar Land
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 6, 2026 · NCT07077746A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou May 27, 2026 · NCT06227910A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou May 22, 2026 · NCT06764615Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT04751396A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT05442567A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Texas Children's Hospital, Houston
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou May 5, 2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Central Texas Clinical Research, LLC, Austin
- Inquest Clinical Research, Baytown
- Novel Research, LLC, Bellaire
- ak 8 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 27, 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400002, Fredericksburg
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Mar 27, 2026 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- ak 5 plis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Houston Methodist Hospital, Houston
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Jan 15, 2026 · NCT06257706Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou May 18, 2021 · NCT04617184Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.